Home | Site map | Elsevier websites | Alerts
Elsevier
Product information search
Search all Elsevier sites
Search
Advanced Product Search
Go to Elsevier home page
SiteStat.jsp
ANTICANCER DRUG DEVELOPMENT
Anticancer Drug Development
To order this title, and for more information, click here

Edited By
Bruce Baguley, The University of Auckland, New Zealand
David Kerr, University of Oxford, United Kingdom

Description
Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided.

Audience
Oncologists, cancer researchers, pharmacologists, molecular biologists, and cell biologists.

Bibliographic details
Hardbound, 397 pages, publication date: OCT-2001
ISBN-13: 978-0-12-072651-6
ISBN-10: 0-12-072651-3
Imprint: ACADEMIC PRESS

Price and Ordering
Price:
EUR 116
USD 141
GBP 80
order now
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.

090/951
Last update: 26 Sep 2008
Reviews
View other people's reviews
Submit your review
Bookmark this page
Recommend this publication
Overview of all books
Printer-friendly version   Printer-friendly version
 Home | Site map | Privacy policy | Terms and Conditions | Feedback | A Reed Elsevier company
 Copyright © 2008 Elsevier B.V. All rights reserved.